2025 annual financial data
Outlook Therapeutics 2025 Net income growth
Direct answer
Net income growth was 17.17%.
Operating income was -67,061,666 USD and net income was -62,424,863 USD.
Operating cash flow was Not available.
Get free Outlook Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,413,535 USD
- Operating income
- -67,061,666 USD
- Net income
- -62,424,863 USD
- Operating cash flow
- Not available